Raymond James analyst William Crow downgrades Sunstone Hotel Invts (NYSE:SHO) from Market Perform to Underperform.
SVB Leerink Maintains Market Perform on Arrowhead Pharmaceuticals, Raises Price Target to $46
SVB Leerink analyst Mani Foroohar maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Market Perform and raises the price target from $45 to $46.